Our Committees

BioCurate’s Committees provide guidance to the Company’s mission to translate new discoveries into novel therapies and to take these to the international market. These committee members bring a global perspective, deep investment expertise and a broad range of pharmaceutical, biotech, medtech, venture capital and start-up experience.
The Hon John Brumby
The Hon John Brumby
Investment Committee
The Hon John Brumby was the former Premier of Victoria, Australia (2007 – 2010) and now continues his active support for innovation and medical research, Chairs a number of for profit and not for profit organisations and is widely published on a range of issues.

Read full profile
Dr Andrea Douglas
Dr Andrea Douglas
Investment Committee
Dr Andrea Douglas is the Senior Vice President, Organisation Transformation and External Affairs at CSL Limited, located at CSL’s headquarters in Parkville, Australia. Dr Douglas leads CSL’s Organisation Transformation Office, which integrates and drives major organisational design changes that have broad implications to the business across areas of strategy, structure, governance, process and people. Dr Douglas also leads CSL’s government affairs strategy in Australia.

Read full profile
Dr Marie Lindner
Investment Committee
Dr Marie Lindner has worked in executive roles in pharmaceutical, biotech, venture capital, start-up and medtech companies with experience across therapeutic areas and modalities and between business and clinical development for over 30 years.

Read full profile
Josephine Wu
Investment Committee
Ms Josephine Wu has over 19 years of hedge fund, family office and global asset management experience specialising in healthcare across the Pan-Asia region.

Read full profile